EBV-IgM

EBV-IGM Test

The EBV IgM test detects IgM antibodies against Epstein-Barr virus (EBV). These antibodies are typically produced by the immune system during the early phase of an EBV infection.

The test can support the evaluation of recent or acute EBV infection, particularly in individuals with symptoms suggestive of infectious mononucleosis, such as fever, sore throat, swollen lymph nodes, and significant fatigue.

EBV IgM results are often interpreted alongside EBV IgG antibodies and other EBV-specific antibody markers, because antibody patterns can provide more information about whether an infection is recent, past, or resolving. A positive IgM result alone does not always establish the exact timing of infection.

This Test is Recommended for Individuals:

• Individuals with suspected recent EBV infection
• Patients with symptoms of infectious mononucleosis
• People experiencing unexplained fever and prolonged fatigue
• Individuals with swollen lymph nodes or persistent sore throat
• Patients with symptoms suggesting a viral infection where EBV is suspected
• Individuals requiring differentiation between recent and previous EBV exposure

FAQs

1. What does a positive EBV IgM result mean?
A positive EBV IgM result may indicate a recent or acute EBV infection. However, it should be interpreted along with other EBV antibody results and clinical symptoms.

2. Is EBV IgM enough to diagnose infectious mononucleosis?
Not always. EBV IgM can support the diagnosis, but healthcare providers may also consider EBV IgG, EBNA antibodies, blood counts, symptoms, and other investigations.

3. What is the difference between EBV IgM and EBV IgG?
EBV IgM is generally associated with a recent infection, while EBV IgG antibodies typically develop during infection and can remain detectable for many years. The combination of results helps determine the likely stage of EBV infection.